We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AACC Competition Demonstrates How Labs Can Use Data Analytics to Solve Real Problems

By LabMedica International staff writers
Posted on 17 Oct 2022
Print article
Image: Advances in machine learning and data analytics are transforming the field of laboratory medicine (Photo courtesy of AACC)
Image: Advances in machine learning and data analytics are transforming the field of laboratory medicine (Photo courtesy of AACC)

Clinicians rely on parathyroid hormone-related peptide (PTHrP) measurement to help establish a diagnosis of humoral hypercalcemia of malignancy - a rare form of cancer that causes, among other things, high levels of calcium in the blood. The problem: Clinicians often order it for patients with low pretest probability. Excessive PTHrP testing can lead to expensive, unnecessary, and potentially harmful procedures, including invasive laboratory testing to locate a possibly nonexistent cancerous tumor. A successful predictive algorithm would help laboratorians quickly and accurately identify potentially inappropriate PTHrP test orders by predicting whether laboratory data available at the time of order already suggest an abnormal PTHrP result. A machine-learning challenge introduced for the first time by the American Association for Clinical Chemistry (Washington, DC, USA; www.aacc.org) at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo demonstrated how laboratories can use data analytics to solve these real problems facing patients and clinicians.

The Predicting PTHrP Results Competition introduced by the AACC at the event in association with the informatics section in the department of pathology and immunology of Washington University School of Medicine, St. Louis (WUSM, St. Louis, MI, USA) aimed to engage the community of laboratory medicine practitioners in a fun and friendly online environment where they could practice their data analytics skills, learn from each other, and see how others approach problems on the data-driven side of laboratory medicine. Competition participants formed teams and used securely shared real, de-identified clinical data from PTHrP orders at WUSM to build their predictive algorithms. This is termed the “practice dataset”. Using real clinical data was a big deal because most machine-learning competitions use synthesized datasets. Organizers set up the competition using Kaggle, a popular online platform for machine-learning modeling and contests, and selected F1 score (the harmonic mean of sensitivity and specificity) as the performance metric.

A major challenge for the teams was developing a predictive model that achieved high accuracy without overfitting it to the public dataset (the practice dataset). Overfitting would mean the algorithm worked well on the initial data but failed if applied to new data and was not generalizable. Organizers used a second, private dataset to judge the algorithm’s effectiveness. From May to June 2022, 24 teams ran a total of 395 iterations of their predictive models through the public dataset. Each time a team submitted a predictive model for an attempt, they used the resulting F1 score to improve - or “train” - the model. For the final attempt, each team ran their predictive model through the private dataset. The winning team, Team Kagglist, achieved an F1 score of 0.9 with their predictive model. For reference, WUSM’s manual approach for identifying patients at risk for PTHrP had an F1 score of 0.6, making the algorithm a significant improvement over standard practice.

“We shouldn’t expect a predictive model trained on data from one hospital to automatically work at other hospitals,” said Team Kaggle’s Yingheng Wang. “Ultimately, we should aim to create adaptive models that can be fine-tuned by other institutions for their specific populations.”

“The quality of all 24 models was excellent and showed a high degree of accuracy for the very difficult task we challenged participants with,” said competition organizer Mark Zaydman, MD, PhD, an assistant professor of pathology and immunology at WUSM. “This competition really showed our community is ready to engage with sophisticated machine learning and data analytics tools.”

Related Links:
AACC 

Gold Supplier
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
New
Hemolysing Reagent
Dialyse-BA 5D
New
Hepatitis/HBcAb CLIA Test
DIA.CHEMILUX HBcAb
New
Rapid Immunological FOB Test
Fecal Occult Blood Test

Print article
SUGENTECH INC.

Channels

Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more

Microbiology

view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more

Pathology

view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.